Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/403251

Files

Bibliographic metadata (17.24 KB)

Primary Published version (428.91 KB)

Type

Authors

Almeida, Beverley

Keywords

32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, Autoimmune Disease, Pediatric Research Initiative, Orphan Drug, Rheumatoid Arthritis, Arthritis, Women's Health, Rare Diseases, Clinical Research, Inflammatory and immune system, 3 Good Health and Well Being

Publisher

Springer Nature

Publisher DOI

https://doi.org/10.1007/s10067-025-07845-7

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/

Collections

Jisc Publications Router